Who Owns Connect Biopharma Stock?
NASDAQ: CNTBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 61.36%
- Held by insiders
- 30.34%
- Institutional holders
- 79
- Institutions 61.4%
- Insiders 30.3%
- Public and other 8.3%
Who owns Connect Biopharma stock?
Institutional investors own about 61.4% of Connect Biopharma's shares, spread across 79 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 30.34% of CNTB.
The largest institutional holders are Ikarian Capital, LLC (7.21%), 683 Capital Management LLC (2.04%) and Boothbay Fund Management, LLC (1.55%). Together, the top 10 institutions control 17.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their CNTB positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CNTB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Ikarian Capital, LLC | 4.54M | 7.21% | -15.8% |
| 683 Capital Management LLC | 1.28M | 2.04% | +42.8% |
| Boothbay Fund Management, LLC | 973.73K | 1.55% | -21.1% |
| Blackrock Inc. | 871.65K | 1.38% | +100.0% |
| Perceptive Advisors Llc | 792.70K | 1.26% | 0.0% |
| Adar1 Capital Management, LLC | 700.00K | 1.11% | -5.7% |
| BML Capital Management, LLC | 573.29K | 0.91% | +40.2% |
| SilverArc Capital Management, LLC | 545.00K | 0.87% | +100.0% |
| Richmond Brothers, Inc. | 535.61K | 0.85% | +12.4% |
| Knott David M., Jr. | 444.86K | 0.71% | +14.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CNTB
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Russell 2000 Growth ETF | 382.53K | 0.61% |
| iShares Trust-iShares Russell 2000 ETF | 378.26K | 0.60% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 160.63K | 0.26% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 58.03K | 0.09% |
| iShares Trust-iShares Micro-Cap ETF | 49.78K | 0.08% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 36.76K | 0.06% |
| TIAA-CREF Funds-Nuveen Small Cap Blend Index Fund | 19.77K | 0.03% |
| Fidelity Salem Street Trust-Fidelity Small Cap Growth Index Fund | 12.65K | 0.02% |
| STATE STREET Inst. INVESTMENT TRT-State Street Small/Mid Cap Eqy. Inde | 11.20K | 0.02% |
| TR PRICE-Price (T.Rowe) U.S. Small Cap Index Trust | 10.19K | 0.02% |
Frequently asked questions
Who is the largest shareholder of Connect Biopharma?
Ikarian Capital, LLC is the largest institutional shareholder of CNTB, owning 7.21% of shares outstanding (4.54M shares) as of its latest 13F filing.
What percentage of Connect Biopharma is owned by institutions?
Institutions own about 61.4% of CNTB shares and 88.1% of the public float.
How much of Connect Biopharma do insiders own?
Insiders, such as officers and directors, own about 30.34% of CNTB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.